Back to search
Steatotic Liver Disease of Mixed Origin (MetALD)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Steatotic Liver Disease of Mixed Origin (MetALD) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Steatotic Liver Disease of Mixed Origin (MetALD) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Steatotic liver disease (SLD) is one of the most prevalent chronic liver diseases worldwide, affecting nearly 30% of the global population and projected to exce…
Liver damage from alcohol intake and weight-related behaviors is preventable and treatable only through lifestyle changes. This mixed-methods randomized control…
The rational to conduct the LOVE study builds on the lack of available data on outcomes in steatotic liver disease in well characterized patients over a time fr…
Steatotic liver diseases (SLD) are the most common chronic liver diseases worldwide. SLD are defined by an excessive liver lipid content (steatosis) of more tha…